Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
148 hedge funds and large institutions have $232M invested in Vaxart in 2022 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 48 reducing their positions, and 22 closing their positions.
73% more call options, than puts
Call options by funds: $6.71M | Put options by funds: $3.87M
1.66% more ownership
Funds ownership: 34.05% → 35.71% (+1.7%)
9% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 22
1% more funds holding
Funds holding: 147 → 148 (+1)
8% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 48
13% less capital invested
Capital invested by funds: $267M → $232M (-$35.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$13.5M |
| 2 |
Morgan Stanley
New York
|
+$5.36M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.09M |
| 4 |
Goldman Sachs
New York
|
+$1.08M |
| 5 |
Rafferty Asset Management
New York
|
+$753K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$2.71M |
| 2 |
Citigroup
New York
|
-$2.53M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.63M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$1.6M |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$1M |
VXRT Hedge Fund Activity: Q1 2022 in Review
148 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2022, worth a combined $232M — down 13% from $267M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new VXRT positions and 22 closed out — a net gain of 2 holders — while 44 added to existing stakes and 48 trimmed.
The largest buyer was State Street, adding an estimated $13.5M. The largest seller was D.E. Shaw & Co, cutting an estimated $2.71M.
- 148 institutional investors held Vaxart (VXRT) as of Q1 2022, up from 147 in Q4 2021.
- Funds reported $232M of Vaxart stock for Q1 2022, down 13% quarter-over-quarter.
- 24 funds opened new Vaxart positions in Q1 2022 and 22 closed out, a net change of +2 holders.
- The largest Vaxart buyer in Q1 2022 was State Street, an estimated $13.5M added.
- The largest Vaxart seller in Q1 2022 was D.E. Shaw & Co, an estimated $2.71M sold.
Based on aggregated 13F filings for Q1 2022.